Indhold på blogs repræsenterer udelukkende de enkelte blogforfatteres holdninger.
Indhold på blogs repræsenterer udelukkende de enkelte blogforfatteres holdninger.
Det er en udbredt opfattelse at influenzavacciner reducerer dødeligheden blandt ældre mennesker, men det passer ikke i følge nye resultater.
Resultaterne, der trykkes i American Journal of Respiratory and Critical Care Medicine, er i modstrid med tidligere undersøgelser.
Konklusionen på den nye undersøgelse er, at selvom influenzavacciner beskytter mod specifikke influenzatyper, er den samlede effekt meget begrænset.
The study included more than 700 matched elderly subjects, half of whom had taken the vaccine and half of whom had not. After controlling for a wealth of variables that were largely not considered or simply not available in previous studies that reported the mortality benefit, the researchers concluded that any such benefit "if present at all, was very small and statistically non-significant and may simply be a healthy-user artifact that they were unable to identify."
"While such a reduction in all-cause mortality would have been impressive, these mortality benefits are likely implausible. Previous studies were likely measuring a benefit not directly attributable to the vaccine itself, but something specific to the individuals who were vaccinated—a healthy-user benefit or frailty bias," said Dean T. Eurich,Ph.D. clinical epidemiologist and assistant professor at the School of Public Health at the University of Alberta. "Over the last two decades in the United Sates, even while vaccination rates among the elderly have increased from 15 to 65 percent, there has been no commensurate decrease in hospital admissions or all-cause mortality. Further, only about 10 percent of winter-time deaths in the United States are attributable to influenza, thus to suggest that the vaccine can reduce 50 percent of deaths from all causes is implausible in our opinion."
Dr. Eurich and colleagues hypothesized that if the healthy-user effect was responsible for the mortality benefit associated with influenza vaccination seen in observational studies, there should also be a significant mortality benefit present during the "off-season".
Læs mere:
http://www.eurekalert.org/pub_re...
Indsend kommentar